The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members.
作者信息
Dannatt Lisa, Ransing Ramdas, Calvey Tanya, Scheibein Florian, Saad Noha Ahmed, Shirasaka Tomohiro, Ramalho Rodrigo, Pant Sagun, Vadivel Ramyadarshni, Siste Kristiana, Stowe M J, Kalita Kamal Narayan, Boujraf Saïd, Testa Roberta, Arya Sidharth, Morgan Nirvana, Grandinetti Paolo
机构信息
Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
Department of Psychiatry, Bhaktshreshtha Kamalakarpant Laxman (BKL) Walalwalkar Rural Medical College, Pune, India.
出版信息
Front Psychiatry. 2021 Mar 2;12:634515. doi: 10.3389/fpsyt.2021.634515. eCollection 2021.
Abstract
摘要
相似文献
1
The Impact of Stigma on Treatment Services for People With Substance Use Disorders During the COVID-19 Pandemic-Perspectives of NECPAM Members.污名化对新冠疫情期间物质使用障碍患者治疗服务的影响——新英格兰成瘾医学医师协会成员的观点
Front Psychiatry. 2021 Mar 2;12:634515. doi: 10.3389/fpsyt.2021.634515. eCollection 2021.
2
Substance use and related harms in the context of COVID-19: a conceptual model.在 COVID-19 背景下的物质使用及相关危害：概念模型。
Health Promot Chronic Dis Prev Can. 2020 Dec 9;40(11-12):342-349. doi: 10.24095/hpcdp.40.11/12.03. Epub 2020 Sep 16.
3
The mental health impact of the COVID-19 pandemic on people with and without depressive, anxiety, or obsessive-compulsive disorders: a longitudinal study of three Dutch case-control cohorts.COVID-19 大流行对有和没有抑郁、焦虑或强迫症的人群的心理健康影响：三项荷兰病例对照队列的纵向研究。
Lancet Psychiatry. 2021 Feb;8(2):121-129. doi: 10.1016/S2215-0366(20)30491-0. Epub 2020 Dec 8.
4
Impact of COVID-19 and other pandemics and epidemics on people with pre-existing mental disorders: a systematic review protocol and suggestions for clinical care.COVID-19 及其他大流行和传染病对患有精神障碍既往史人群的影响：系统综述方案及临床照护建议。
BMJ Open. 2020 Sep 1;10(9):e040229. doi: 10.1136/bmjopen-2020-040229.
5
Ethno-cultural disparities in mental health during the COVID-19 pandemic: a cross-sectional study on the impact of exposure to the virus and COVID-19-related discrimination and stigma on mental health across ethno-cultural groups in Quebec (Canada).新冠疫情期间心理健康方面的种族文化差异：一项关于接触病毒以及与新冠疫情相关的歧视和污名化对加拿大魁北克省不同种族文化群体心理健康影响的横断面研究。
BJPsych Open. 2020 Dec 9;7(1):e14. doi: 10.1192/bjo.2020.146.
6
Access to Healthcare and Harm Reduction Services During the COVID-19 Pandemic for People Who Use Drugs.在 COVID-19 大流行期间，吸毒者获得医疗保健和减少伤害服务的机会。
J Addict Med. 2020 Dec;14(6):e287-e289. doi: 10.1097/ADM.0000000000000753.
7
[THE COVID-19 PANDEMIC: DEPRESSION, ANXIETY, STIGMA AND IMPACT ON MENTAL HEALTH].[新冠疫情：抑郁、焦虑、污名化及其对心理健康的影响]
Probl Sotsialnoi Gig Zdravookhranenniiai Istor Med. 2020 Sep;28(5):922-927. doi: 10.32687/0869-866X-2020-28-5-922-927.
8
Weight Stigma as a Predictor of Distress and Maladaptive Eating Behaviors During COVID-19: Longitudinal Findings From the EAT Study.体重歧视预测 COVID-19 期间的困扰和不良进食行为：EAT 研究的纵向发现。
Ann Behav Med. 2020 Oct 1;54(10):738-746. doi: 10.1093/abm/kaaa077.
9
COVID-19 and Mental Health/Substance Use Disorders on Reddit: A Longitudinal Study.Reddit上的新冠疫情与心理健康/物质使用障碍：一项纵向研究
ArXiv. 2020 Nov 20:arXiv:2011.10518v1.
10
COVID-19 and persons with substance use disorders: Inequities and mitigation strategies.新型冠状病毒肺炎与物质使用障碍患者：不公平现象与缓解策略。
Subst Abus. 2020;41(3):286-291. doi: 10.1080/08897077.2020.1784363.
引用本文的文献
1
Treatment rates and delays for mental and substance use disorders: results from the Australian National Survey of Mental Health and Wellbeing.精神和物质使用障碍的治疗率及延误情况：澳大利亚全国心理健康与幸福调查结果
Epidemiol Psychiatr Sci. 2025 Feb 14;34:e8. doi: 10.1017/S2045796025000034.
2
Substance abuse among new patients attending main government hospitals in Malaysia from 2018-2021: A comparison between before and during COVID-19 pandemic.2018-2021 年期间，马来西亚主要政府医院新就诊患者的药物滥用情况：新冠疫情前后的比较。
PLoS One. 2024 Oct 24;19(10):e0309422. doi: 10.1371/journal.pone.0309422. eCollection 2024.
3
Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020-August 2021.美国 COVID-19 大流行期间按地理位置和物质类型划分的过量致命过量情况：2020 年 3 月至 2021 年 8 月。
Am J Public Health. 2024 Jun;114(6):599-609. doi: 10.2105/AJPH.2024.307618.
4
Uptake of SARS-CoV-2 vaccination among structurally-marginalized people who use drugs in Vancouver, Canada.在加拿大温哥华，结构性边缘人群（使用毒品的人）对 SARS-CoV-2 疫苗的接种率。
Sci Rep. 2023 Oct 20;13(1):17930. doi: 10.1038/s41598-023-44069-8.
5
Health-related quality of life and stigma in opioid dependence: Comparison between buprenorphine users and non-users.阿片类药物依赖患者的健康相关生活质量与耻辱感：丁丙诺啡使用者与非使用者的比较。
J Neurosci Rural Pract. 2023 Jul-Sep;14(3):453-458. doi: 10.25259/JNRP_109_2023. Epub 2023 May 23.
6
"It's just a perfect storm": Exploring the consequences of the COVID-19 pandemic on overdose risk in British Columbia from the perspectives of people who use substances.“这简直是完美风暴”：从使用物质的人的角度探讨 COVID-19 大流行对不列颠哥伦比亚省药物过量风险的影响。
BMC Public Health. 2023 Apr 3;23(1):640. doi: 10.1186/s12889-023-15474-5.
7
Trends in cannabis or cocaine-related dependence and alcohol/drug treatment in Argentina, Chile, and Uruguay.阿根廷、智利和乌拉圭的大麻或可卡因相关依赖及酒精/药物治疗趋势。
Int J Drug Policy. 2022 Oct;108:103810. doi: 10.1016/j.drugpo.2022.103810. Epub 2022 Aug 5.
8
A multicentric survey among patients with substance use disorders during the COVID-19 lockdown in India.印度新冠疫情封锁期间针对物质使用障碍患者的多中心调查。
Indian J Psychiatry. 2022 Jan-Feb;64(1):48-55. doi: 10.4103/indianjpsychiatry.indianjpsychiatry_557_21. Epub 2022 Jan 21.
9
Supporting the Health of HIV-Positive People Who Inject Drugs During COVID-19 and Beyond: Lessons for the United States from St. Petersburg, Russia.在新冠疫情期间及之后支持注射吸毒的艾滋病毒阳性者的健康：俄罗斯圣彼得堡给美国的启示
Am J Public Health. 2022 Apr;112(S2):S123-S127. doi: 10.2105/AJPH.2022.306727.
10
Substance use disorders during the COVID-19 pandemic: looking for new innovative approaches.新冠疫情期间的物质使用障碍：寻找新的创新方法。
Acta Biomed. 2022 Mar 14;93(1):e2022081. doi: 10.23750/abm.v93i1.12612.
本文引用的文献
1
Harm reduction in the time of COVID-19: Case study of homelessness and drug use in Dublin, Ireland.在 COVID-19 时代的减少伤害：爱尔兰都柏林无家可归和吸毒问题的案例研究。
Int J Drug Policy. 2021 Jan;87:102966. doi: 10.1016/j.drugpo.2020.102966. Epub 2020 Nov 7.
2
Harm reduction in an emergency response to homelessness during South Africa's COVID-19 lockdown.在南非 COVID-19 封锁期间应对无家可归问题的紧急响应中的减少伤害。
Harm Reduct J. 2020 Aug 24;17(1):60. doi: 10.1186/s12954-020-00404-0.
3
Motivations, facilitators and barriers to accessing hepatitis C treatment among people who inject drugs in two South African cities.南非两个城市中注射毒品者获得丙型肝炎治疗的动机、促进因素和障碍。
Harm Reduct J. 2020 Jun 10;17(1):39. doi: 10.1186/s12954-020-00382-3.
4
Collision of the COVID-19 and Addiction Epidemics.新冠肺炎与成瘾流行病的碰撞。
Ann Intern Med. 2020 Jul 7;173(1):61-62. doi: 10.7326/M20-1212. Epub 2020 Apr 2.
5
Negative Impacts of Self-Stigma on the Quality of Life of Patients in Methadone Maintenance Treatment: The Mediated Roles of Psychological Distress and Social Functioning.美沙酮维持治疗患者自我污名对生活质量的负面影响：心理困扰和社会功能的中介作用。
Int J Environ Res Public Health. 2019 Apr 11;16(7):1299. doi: 10.3390/ijerph16071299.
6
Internalized stigma among patients with substance use disorders at a tertiary care center in India.印度一家三级护理中心物质使用障碍患者的内化耻辱感。
J Ethn Subst Abuse. 2019 Jul-Sep;18(3):345-358. doi: 10.1080/15332640.2017.1357158. Epub 2017 Sep 12.
7
Stigma and substance use disorders: an international phenomenon.耻辱感与物质使用障碍：一种国际现象。
Curr Opin Psychiatry. 2017 Sep;30(5):378-388. doi: 10.1097/YCO.0000000000000351.
8
A qualitative assessment of methadone maintenance therapy program in Nepal: evidence to scaling up at national level.尼泊尔美沙酮维持治疗项目的定性评估：在国家层面扩大规模的证据
Nepal Med Coll J. 2014 Sep;16(1):17-9.
9
Opioid substitution treatment in New Zealand: a 40 year perspective.新西兰的阿片类药物替代治疗：40年回顾
N Z Med J. 2014 Jul 4;127(1397):57-66.
10
Confronting the stigma of opioid use disorder--and its treatment.直面阿片类药物使用障碍的污名化现象及其治疗。
JAMA. 2014 Apr 9;311(14):1393-4. doi: 10.1001/jama.2014.2147.
Zotero 插件